No to Astellas' shareholder ripoff!
Donation protected
America is close to losing some of the most important medical intellectual property ever developed.
Stockholders of Ocata Therapeutics, a leader in Regenerative Medicine, are locked in a battle to fend off a Tender Offer. Defeated twice, Astellas Pharma, a Japanese company, has initiated a third attempt to purchase Ocata.
The opposition from a majority of the shareholders has been significant. Yet they are in a position to lose this battle and need to mount a strong awareness marketing campaign.
This is a pervasive problem in the market that allows institutions and management to cash-in at the expense of small shareholders.
Your support could be the difference between this hugely important intellectual estate remaining in the US, or being transferred to a foreign country.
All funding will be used to pay for legal guidance, data acquisition, and various shareholder and consumer awareness campaigns.
Shareholders:
You can oppose this Tender Offer by doing nothing.
If solicited to tender your shares, just say “No”
If you have tendered your shares, you must contact your broker to cancel (rescind, un-tender) your shares.
DO NOT call (866) [phone redacted] to cancel tendered shares.
Stockholders of Ocata Therapeutics, a leader in Regenerative Medicine, are locked in a battle to fend off a Tender Offer. Defeated twice, Astellas Pharma, a Japanese company, has initiated a third attempt to purchase Ocata.
The opposition from a majority of the shareholders has been significant. Yet they are in a position to lose this battle and need to mount a strong awareness marketing campaign.
This is a pervasive problem in the market that allows institutions and management to cash-in at the expense of small shareholders.
Your support could be the difference between this hugely important intellectual estate remaining in the US, or being transferred to a foreign country.
All funding will be used to pay for legal guidance, data acquisition, and various shareholder and consumer awareness campaigns.
Shareholders:
You can oppose this Tender Offer by doing nothing.
If solicited to tender your shares, just say “No”
If you have tendered your shares, you must contact your broker to cancel (rescind, un-tender) your shares.
DO NOT call (866) [phone redacted] to cancel tendered shares.
Organizer
Ted Slatten
Organizer
Tacoma, WA